MEDical Research Valorisation through Intelligent Engagement of Citizens for Well-being

MEDVIEW builds on the growing recognition that achieving good health in a community requires much more than medical and technical solutions available only in selected places and circumstances. Citizens’ health priorities stem from their everyday experiences and needs and differ from professionals’ priorities. There is a growing demand for a more ""human-centric"" approach to tackle the complexity of achieving overall human well-being. It is widely accepted that involving citizens in the design of products, services, and policies that impact their health, lives, and communities is thought to improve their overall quality and effectiveness. Citizens’ voices can act as a mechanism for change ensuring that the created solutions are more integrated around communities’ needs instead of centered on organisations’ traditional remits. MEDVIEW aims to create an enabling environment for innovation, collaboration, and effective co-creation between industry partners, citizens (patients, community members), health practitioners, doctors, researchers, academia, and policymakers to address the complex issue of human health & well-being. To succeed so, we have carefully selected partners from three WIDENING countries [LT, GR, SLO] and two of non WIDENING countries [LUX, BE] addressing the following selection criteria: - Wide geographical reach, representing a rich tapestry of cultures, languages, and healthcare/wellbeing systems - Specialized expertise and a solid track record of all partners in coordination and support activities both at the national as well as in an international level - Representation of all target groups as defined by the Call The project will ultimately deliver the MEDVIEW Knowledge Valorisation Implementation Guide, a complete practical guide, and the relevant tools comprised of methods, practices, and procedures for the deployment of an open innovation space for effective knowledge valorisation in the field of well-being.